You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LABA

Showing 1 - 25 of 491
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Exercise Performance Trial in Copenhagen (Symbicort, Formoterol, Placebo)

Not yet recruiting
  • Exercise Performance
  • Copenhagen, Denmark
    August Krogh Building
Oct 23, 2023

Exercise Performance Trial in Copenhagen (Indacaterol and Mometasonefluroate (low dose), Placebo, Indacaterol and

Recruiting
  • Exercise Performance
  • Indacaterol and Mometasonefluroate (low dose)
  • +2 more
  • Copenhagen, Denmark
    August Krogh Building
Oct 4, 2023

Exercise Performance Trial in Copenhagen (Vilanterol and Fluticasone Furoate (low dose), Vilanterol and Fluticasone Furoate

Recruiting
  • Exercise Performance
  • Vilanterol and Fluticasone Furoate (low dose)
  • +2 more
  • Copenhagen, DK, Denmark
    August Krogh Building
Sep 27, 2023

Pathways of Asthamics Treated With ICS/LABA/LAMA Therapy

Not yet recruiting
  • Asthma
  • (no location specified)
Oct 24, 2023

Exacerbation Risk in Asthma

Completed
  • Asthma
  • White Plains, New York
    eMax Health
Aug 12, 2022

Tiotropium + Olodaterol Versus Inhaled Corticosteroids +

Active, not recruiting
  • Pulmonary Disease, Chronic Obstructive
  • Tiotropium (Tio)
  • +4 more
  • Taipei, China
    National Tawain University Hospital
Jan 9, 2023

Asthma in Children, Nonadherence, Medication Trial in Saint Louis (Adherence to symptom driven budesonide/formoterol as compared

Recruiting
  • Asthma in Children
  • Nonadherence, Medication
  • Adherence to symptom driven budesonide/formoterol as compared to adherence to maintenance ICS and symptom-driven SABA
  • Saint Louis, Missouri
    Washington University in St. Louis School of Medicine
Jan 9, 2023

A Multicentre, Prospective, Non-interventional Trial Monitoring

Not yet recruiting
  • ASTHMA
  • Non-interventional
  • (no location specified)
Feb 6, 2023

Blood Leukocyte Profiling in Eosinophilic Type 2 Asthma:

Recruiting
  • Asthma
  • Mepolizumab
  • Standard inhaled corticosteroids (ICS) and long-acting beta 2 agonists (LABA)
  • Lund, Skane, Sweden
    The Lung and Allergy Clinic, Skåne University Hospital (SUS)
Jan 16, 2023

Fixed LAMA/LABA/ICS Triple Therapy

Completed
  • COPD
  • Non-interventional
  • Liverpool, United Kingdom
    Liverpool Heart and Chest Foundation Trust
Jul 20, 2022

ivenesS of BDP/FF/G Fixed triPle cOmbiNation on Symptom scorEs

Not yet recruiting
  • COPD
    • Budapest, Hungary
      National Korányi Institute of Pulmonology
    Feb 15, 2023

    Pulmonary Disease, Chronic Obstructive Trial in Brussels (LABA, LAMA)

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • Brussels, Belgium
      Erasme University Hospital
    Jun 23, 2023

    Moderate Asthma Trial (Long-Acting Beta Agonist)

    Not yet recruiting
    • Moderate Asthma
    • Long-Acting Beta Agonist
    • (no location specified)
    Feb 24, 2023

    South Korea Using Medical Records to Look at Different

    Completed
    Has Results
    • Pulmonary Disease, Chronic Obstructive
    • Long-acting Muscarinic Antagonists (LAMA)
    • Inhaled corticosteroid (ICS)/Long-acting Beta Agonists (LABA)
    • Seoul, Korea, Republic of
      Konkuk University Medical Center
    Feb 8, 2022

    Copd Trial in Assiut (SABA SAMA ICS Vs LABA LAMA ICs)

    Not yet recruiting
    • Copd
    • SABA SAMA ICS Vs LABA LAMA ICs
    • Assiut, Egypt
      Nermen Mohammed Abuelkassem
    Feb 28, 2023

    Pathways of Asthma Patients Treated WithExtrafine ICS/LABA/LAMA

    Recruiting
    • Asthma
    • Non-interventional
    • Durham, County Durham, United Kingdom
      The Haven Surgery, The Haven, Burnhope,
    Jul 20, 2022

    Copd Trial in Dallas (TRELEGY ELLIPTA 100Mcg-62.5Mcg-25Mcg/Actuation Powder for Inhalation)

    Not yet recruiting
    • Copd
    • TRELEGY ELLIPTA 100Mcg-62.5Mcg-25Mcg/Actuation Powder for Inhalation
    • Dallas, Texas
      Baylor Scott & White Health Research Institute
    Mar 22, 2022

    COPD Trial in Mexico City (Fluticasone Furoate/Vilanterol 100/25 mcgs, Umeclidinium/Vilanterol 62.5/25 mcgs)

    Completed
    • COPD
    • Fluticasone Furoate/Vilanterol 100/25 mcgs
    • Umeclidinium/Vilanterol 62.5/25 mcgs
    • Mexico City, Tlalpan, Mexico
      National Institute of Respiratory Diseases 'Ismael Cosío Villega
    Apr 18, 2022

    Fixed-dose Dual Bronchodilator in Heart Insufficiency and COPD

    Withdrawn
    • COPD
    • Spiolto® Respimat® (Tiotropium / Olodaterol)
    • Aachen, North Rhine Westphalia, Germany
      Clinic of Cardiology, Angiology, Pneumology and Intensive Medici
    Oct 25, 2022

    Moderate to Severe Asthma Trial (povorcitinib, , ICS-LABA)

    Not yet recruiting
    • Moderate to Severe Asthma
    • (no location specified)
    May 9, 2023

    Tiotropium and Olodaterol in Comparison to LABA/ICS

    Completed
    Has Results
    • COPD
    • Watertown, Massachusetts
      HealthCore, Inc.
    Nov 12, 2021

    Asthma, Chest Syndrome, Azithromycin Trial in China (Azithromycin, ICS/LABA)

    Not yet recruiting
    • Asthma
    • +3 more
    • Beijing, Beijing, China
    • +12 more
    Nov 2, 2022

    Asthma Trial in Nyíregyháza (Administration via pressurized metered dose inhaler (pMDI))

    Recruiting
    • Asthma
    • Administration via pressurized metered dose inhaler (pMDI)
    • Nyíregyháza, Hungary
      Simplex Kft
    Mar 14, 2022

    Asthma Trial in Worldwide (AZD4604, Placebo)

    Not yet recruiting
    • Asthma
    • Stockton, California
    • +24 more
    Aug 25, 2023

    Asthma, Nonadherence, Medication Trial in Saint Louis (Adherence to symptom driven budesonide/formoterol as compared to

    Recruiting
    • Asthma
    • Nonadherence, Medication
    • Adherence to symptom driven budesonide/formoterol as compared to adherence to maintenance ICS and symptom-driven SABA
    • Saint Louis, Missouri
      Washington University in St. Louis School of Medicine
    Jan 8, 2023